Camizestrant- 2222844-89-3
1 Inquiries
2222844-89-3
Pharmaceutical Grade
99%
china
1g
2026-10-04
peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCamizestrant is an orally available selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon administration, camizestrant binds to the estrogen receptor (ER) and induces a conformational change that results in the degradation of the receptor. This prevents ER-mediated signaling and inhibits the growth and survival of ER-expressing cancer cells.Basic Info
-
Product Name:
Unii-jup57A8epz
Other Name:AZD-9833;Camizestrant;AZD9833;UNII-JUP57A8EPZ;JUP57A8EPZ;2222844-89-3;AZ14066724;Camizestrant [USAN];CHEMBL4650365;SCHEMBL20089710
CAS No.:2222844-89-3
Molecular Formula:C24H28F4N6
InChIKeys:WDHOIABIERMLGY-CMJOXMDJSA-N
Exact Mass:476.23115757
UNII:JUP57A8EPZ
NCI Thesaurus Code:C160603
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
126 AUTUMN ROAD ,LAKEWOOD NEW JERSEY
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
-
Certifications:
certifacate for peptieds
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
United States
Camizestrant
1 KG Sep 5, 2026 Post an enquiry for this product